Abstract
To research for host genes for resistance/susceptibility to cancer metastasis, mutation analysis was employed. Ten putative mutants of resistance to lymphoma EL4 and four putative mutants of resistance to sarcoma MCA/77-23 of C57BL/6J (B6) mice were produced. These mutants were designated s (for “survivor”) mutants; they do not reject parental strain B6 skin grafts. S-mutants resist moderate tumor cell doses: TD50 values in them were increased by a factor of 12 to 600. Genetic linkage tests showed that five S-mutants were linked to mouse major histocompatibility complex (H-2) and five other S-mutants were not linked to this locus. A group of H-2-linked S-mutants resisting EL4 and a mutant, S-87/2, resisting MCA/77-23 were tested for resistance to spontaneous matastases of the same two tumors, EL4 and MCA/77-23. Two of the mutants, S-31 (lymphoma-resisting) and S-87/2 (sarcoma-resisting), were shown to carry mutations of mouse gene(s) for resistance to tumor metastases. In both of these mutants resistance to the original tumor transplant coexisted with highly increased susceptibility to meatastasis. These mutants are a new tool to study genes for resistance to cancer metastasis and of mechanism of resistance controlled by each individual gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bennett, M.: Biology and genetics of hybrid resistance. Adv Immunol 41: 333–445, 1987
Dear, T. N. and Kefford, R. F.: Molecular oncogenetics of metastasis. Molec Aspects Med 11: 243–324, 1990
Drizlikh, G., Shmidt-Sole, J., and Yankelevich, B.: Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts. J Exp Med 159: 1070–1082, 1984
Egorov, I. K. and Blandova, Z. K.: Histocompatibility mutations in mice: chemical induction and linkage with the H-2 locus. Genet Res 19: 133–143, 1972
Egorov, I. K. and Egorov, O. S.: Detection of new MHC mutations in mice by skin grafting, tumor transplantation, and monoclonal antibodies: a comparison. Genetics 118: 287–298, 1988
Egorov, O. S., Sargent, E., Carlson, G. A., and Egorov, I. K.: Mouse mutants affecting growth and metastasis of a syngeneic tumor. In I. K. Egorov and C. S. David (eds.): Transgenic Mice and Mutants in MHC Research, pp. 276–281, Springer, New York, 1990
Egorov, O. S., Liu, Y., and Egorov, I. K.: Possible role of Ab b gene in mouse resistance to EL4 metastases. Immunogenetics 36: this issue
Evans, R.: Further observations of the effect of cyclophosphamide on intratumor and peripheral leukocyte levels. Am J Pathol 99: 667–684, 1980
Fearon, E. R. and Vogelstein, B.: A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990
Gorer, P. A.: Studies in antibody response of mice to tumor inoculation. Br J Cancer 4: 372–379, 1950
Grossman, Z. and Herberman, R. B.: “Immune surveillance” without immunogenecity. Immunol Today 7: 128–131, 1986
Günthert, U., Hofman, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P.: A new variant of clycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24, 1991
Hellström, K. E. and Hellström, I.: Oncogene-associated tumor antigens as targets for immunotherapy. FASEB J 3: 1715–1722, 1989
Joshi, S. S. and Brunson, K. W.: Differential cell surface antigen expression on metastatic variant lymphoma cell lines. Oncology 47: 339–343, 1990
Leone, A., Flatow, U., King, C. R., sandeen, M. A., Margulies, I. M. K., Liotta, L. A., and Steeg, P. S.: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of Inm23-transfected melanoma cells. Cell 65: 25–35, 1991
Millikin, D., Meese, E., Vogelstein, B., Witkowski, C., and Trent, j.: Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51: 5449–5453, 1991
Poste, G., Doll, J., and Fidler, I. J.: Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 78: 6226–6230, 1981
Pozatti, R., McCormick, M., Thompson, M. A., and Khoury, G.: The Ela gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat enbrio cells. Mol Cell Biol 8: 2984–2988, 1988
Uyttenhove, C., Van Snick, J., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815: rejection by syngeneic mice. J Exp Med 152: 1175–1183, 1980
Viadana, E., Bross, I. D. J., and Pickren, J. W. In L. Weiss and H. Gilbert (eds.): Pulmonary Metastases, pp. 142–167, Hall, Boston, MA, 1978
Author information
Authors and Affiliations
Additional information
Address corresponding and offprint request to: I. K. Egorov.
Rights and permissions
About this article
Cite this article
Egorov, O.S., Liu, Y., Sargent, E.E. et al. Screening mouse mutations for resistance to cancer metastasis. Immunogenetics 36, 219–223 (1992). https://doi.org/10.1007/BF00215051
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00215051